Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TPH, SLC6A2, SLC6A3, DRD2 and DRD4 Polymorphisms and Neuroendocrine Factors Predict SSRIs Treatment Outcome in the Chinese Population with Major Depression.

Pharmacopsychiatry - 1 May 2015

Yin L, Zhang Y Y, Zhang X, Yu T, He G, Sun X L

Abstract excerpt

OBJECTIVE: This study was intended to determine whether antidepressant outcome to SSRIs was associated with catecholamine gene polymorphisms and neuroendocrine factors in patients of Chinese Han ethnicity with MDD. METHOD: A total of 290 MDD patients were recruited and received a 6-week randomized double-blinded treatment. Cortisol, adrenocorticotropic hormone (ACTH), thyroid-stimulating hormone (TSH),...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents
Share to Dopamine Plasma Membrane Transport Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Double-Blind Method

Share to Neurosecretory Systems

Share to Norepinephrine Plasma Membrane Transport Proteins

Share to Receptors, Dopamine D4

Share to Selective Serotonin Reuptake Inhibitors

Share to Tryptophan Hydroxylase

Source

Identifiers

PMID: 25642918
DOI: 10.1055/s-0034-1398508

Genes

DRD4
DRD2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TPH, SLC6A2, SLC6A3, DRD2 and DRD4 Polymorphisms and Neuroendocrine Factors Predict SSRIs Treatment Outcome in the Chinese Population with Major Depression.PMID 25642918Read ↗

Catecholamine pathway polymorphisms and antidepressant response.Semantic proximity Read ↗

Neither cytochrome P450 family genes nor neuroendocrine factors could independently predict the SSRIs treatment in the Chinese Han population.Semantic proximity Read ↗

A novel NR3C2 polymorphism and the increased thyroid-stimulating hormone concentration are associated with venlafaxine treatment outcome in Chinese Han MDD patients.Semantic proximity Read ↗

The association between polymorphism of norepinephrine transporter G1287A and major depressive disorder, antidepressant response: a meta-analysis.Semantic proximity Read ↗

HTR2A is associated with SSRI response in major depressive disorder in a Japanese cohort.Semantic proximity Read ↗

<em>5-HTR1A</em> and <em>5-HTR2A </em>genetic polymorphisms and SSRI antidepressant response in depressive Chinese patientsSemantic proximity Read ↗

Association analysis of SIGMAR1 with major depressive disorder and SSRI response.Semantic proximity Read ↗

The GG genotype of the serotonin 4 receptor genetic polymorphism, rs1345697, is associated with lower remission rates after antidepressant treatment: Findings from the METADAP cohort.Semantic proximity Read ↗

Association of serotonin transporter (SLC6A4) and receptor (5HTR1A, 5HTR2A) polymorphisms with response to treatment with escitalopram in patients with major depressive disorder: A preliminary study.Semantic proximity Read ↗

Associations between the 1438A/G, 102T/C, and rs7997012G/A polymorphisms of HTR2A and the safety and efficacy of antidepressants in depression: a meta-analysis.Semantic proximity Read ↗

No Association Between SLC6A4 Gene Polymorphisms With Treatment Remission to Venlafaxine in Han Chinese Depressive Patients.Semantic proximity Read ↗

Genomic predictors of response to antidepressants in Major depressive disorder (MDD): A GWAS-Based Study on Indian cohortSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.